Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
The latest update is out from ValiRx plc ( (GB:VAL) ).
ValiRx plc has announced a change in major holdings, with Peel Hunt LLP acquiring or disposing of voting rights, resulting in a 10.327209% stake in the company as of December 30, 2024. This change in ownership could impact ValiRx’s corporate governance and strategic decisions, potentially influencing its future growth and positioning in the biotechnology industry.
More about ValiRx plc
ValiRx plc is a UK-based company operating in the biotechnology sector, focusing on the development of cancer therapeutics and diagnostics. The company is engaged in advancing innovative treatments and technologies to address unmet medical needs in the oncology market.
YTD Price Performance: -89.41%
Average Trading Volume: 2,365,028
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £827.2K
For an in-depth examination of VAL stock, go to TipRanks’ Stock Analysis page.
